bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Taysha Gene Therapies Inc. logo

    Taysha Gene Therapies Inc.

    TSHA | NASDAQ
    Chart Builder DCF Calculator
    $5.04
    +$0.02 (+0.40%)
    At close: Sep 21, 2026, 4:00 PM ET
    $5.14
    +$0.10 (+1.98%)
    Pre-market: Sep 22, 2026, 9:10 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.61B
    Enterprise Value
    $1.21B
    Beta
    1.17
    Average Volume
    2.87M
    Shares Outstanding (Diluted)
    369.04M
    Shares Change YoY
    23.84%
    Institutional Ownership
    72.45%
    Exchange
    NASDAQ
    ISIN
    US8776191061

    Price Performance

    Price Change 1M
    -15.7%
    Price Change 3M
    -26.5%
    Price Change 6M
    10.0%
    Price Change YTD
    -4.0%
    Price Change 1Y
    75.6%
    Price Change 3Y
    72.0%
    Price Change 5Y
    -74.8%
    1M CAGR (ann.)
    -23.2%
    1Y CAGR (ann.)
    68.6%
    5Y CAGR (ann.)
    -24.4%
    All-Time CAGR
    -22.9%

    Valuation

    PE Ratio
    -12.00
    Forward PE
    N/A
    PEG Ratio
    0.72
    Forward PEG
    -2.37
    PS Ratio
    293.91
    Forward PS
    56.60
    PB Ratio
    4.16
    P/FCF Ratio
    -11.89
    P/Adj. FCF Ratio
    -10.49
    P/OCF Ratio
    -14.00
    EV/Sales
    221.01
    EV/EBIT
    -8.08
    EV/EBITDA
    -8.15
    EV/FCF
    -8.94
    Earnings Yield
    -8.3%
    FCF Yield
    -8.4%
    Adj. FCF Yield
    -9.5%

    Financial Health

    Net Cash
    $406.15M
    Total Debt
    $55.55M
    Cash & Short-Term Investments
    $455.41M
    Total Assets
    $470.43M
    Current Ratio
    17.76
    Quick Ratio
    17.76
    Debt / Equity Ratio
    0.14
    Debt / EBITDA
    -0.37
    Debt / FCF
    -0.41
    OCF / Debt
    -2.38
    Interest Coverage
    -3,646.64
    Altman Z-Score
    9.32
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    84.0%
    Operating Profit Margin
    -2792.3%
    EBITDA Margin
    -2712.3%
    Net Profit Margin
    -2728.0%
    FCF Margin
    -2471.7%
    Adj. FCF Margin
    -2803.0%
    SBC / Revenue
    331.3%
    SBC Impact (per share)
    -13.4%

    Returns

    Return on Assets
    -31.8%
    Return on Equity
    -56.2%
    Return on Invested Capital
    -34.5%
    Return on Capital Employed
    -34.5%
    Return on Tangible Assets
    -31.8%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -17.0%
    Revenue CAGR 5Y
    13.1%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    40.9%
    EPS CAGR 5Y
    61.3%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -28.4%
    FCF CAGR 5Y
    6.1%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    18
    EPS Growth Next 3Y
    61.1%
    Revenue Growth Next 3Y
    361.9%
    Earnings Date
    Nov 2, 2026
    EPS Estimate (next Q)
    -$0.14
    EPS Growth Est (next Q)
    55.6%
    Revenue Est (next Q)
    $755.56K
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $14
    Price Target Upside
    177.8%

    Cash Flow

    Operating Cash Flow
    $-132.19M
    Free Cash Flow
    $-135.57M
    Adj. Free Cash Flow
    $-153.74M
    FCF Per Share
    -$0.37
    OCF Per Share
    -$0.36
    OCF/S Ratio
    -2410.0%

    Income Statement

    Revenue
    $5.49M
    Gross Profit
    $4.61M
    Operating Income
    $-153.16M
    EBITDA
    $-148.77M
    Net Income
    $-149.63M
    EPS (Diluted)
    -$0.42
    Revenue / Employee
    $55.4K
    Profit / Employee
    $-1.51M
    Employees
    99

    © 2026 bestshares.com. All rights reserved.